During the past decade, Institut Jantung Negara conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 21 clinical trials were completed, i.e. on average, 51.2% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 12 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Jantung Negara" #1 sponsor was "Actelion" with 14 trials, followed by "Boston Scientific Corporation" with 10 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 9 trials sponsored, "Abbott Medical Devices" with 4 trials sponsored and "Bayer" with 4 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Jantung Negara" #1 collaborator was "Boston Scientific Corporation" with 2 trials as a collaborator, "Medtronic" with 2 trials as a collaborator, "ATTRaCT program by A*STAR BMRC Singapore" with 1 trials as a collaborator, "Abbott Diagnostics Division" with 1 trials as a collaborator and "Abbott Medical Devices" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Institut Jantung Negara" are "Pulmonary Arterial Hypertension" (12 trials), "Coronary Artery Disease" (11 trials), "Heart Failure" (10 trials), "Atrial Fibrillation" (6 trials) and "Bradycardia" (3 trials). Many other conditions were trialed in "Institut Jantung Negara" in a lesser frequency.

Most popular intervention types in "Institut Jantung Negara" are "Device" (36 trials), "Drug" (24 trials), "Other" (4 trials), "Procedure" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Macitentan" (3 trials), "Macitentan 10 mg" (3 trials), "Selexipag" (3 trials) and "ABSORB BVS" (1 trials). Other intervention names were less common.

The vast majority of trials in "Institut Jantung Negara" are 66 trials for "All" genders.

Currently, there are NaN active trials in "Institut Jantung Negara". undefined are not yet recruiting, 6 are recruiting, 10 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 36 completed trials in Institut Jantung Negara, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Institut Jantung Negara, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 25 trials that are defined as “Not Applicable".